THE serotonin (5-HT) receptor subtype mediating inhibition of neurogen
ic dural inflammation in guinea pigs was investigated using a series o
f serotonin agonists differing affinities for the 5-HT1B, 5-HT1D and 5
-HT1F receptors. When agonist potencies for inhibiting neurogenic infl
ammation were compared with affinities for these receptor subtypes, a
significant positive correlation was seen only with the 5-HT1F recepto
r. The potency of agonists in inhibiting adenylate cyclase in cells tr
ansfected with human 5-HT1F receptor was also highly correlated with t
heir potency in the animal model of migraine. In situ hybridization de
monstrated 5-HT1F receptor mRNA in guinea pig trigeminal ganglion neur
ons. These data suggest that the 5-HT1F receptor is a rational target
for migraine therapeutics.